Results 1 to 10 of about 50,472 (324)

Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation

open access: yesClinical Hematology International, 2022
Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment strategy in patients with a hematological disorder. Chemotherapy-induced nausea and vomiting (CINV) is still an issue in patients who undergo HSCT.
Sayako Yuda   +3 more
doaj   +2 more sources

Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy. [PDF]

open access: bronze, 2011
Our study shows that in Indonesian cancer patients treated with highly cytostatic emetogenic, carriership of the CTG haplotype of the ABCB1 gene is related to an increased risk of delayed chemotherapy-induced nausea and ...
Baak-Pablo, Renee F   +8 more
core   +4 more sources

How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature

open access: goldClinical Parkinsonism & Related Disorders, 2023
Introduction: Pretreatment with the antiemetic trimethobenzamide has been recommended practice in the United States (US) to address the risk of nausea and vomiting during initiation of apomorphine treatment.
Stuart H. Isaacson   +3 more
doaj   +2 more sources

Impact of antiemetic steroid use on survival in small cell lung cancer patients receiving immune checkpoint inhibitors and chemotherapy [PDF]

open access: yesScientific Reports
Immune checkpoint inhibitors (ICIs) combined with conventional cytotoxic agents have become the new standard of care for extensive-stage small cell lung cancer (SCLC).
Soh Mee Park   +3 more
doaj   +2 more sources

Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine [PDF]

open access: yesArchives of Razi Institute, 2021
Substance P binds to the Neurokinin-1 (NK-1) receptors found in the emetic center of the central nervous system (CNS) to induce emesis. Maropitant is a selective NK-1 receptor antagonist that inhibits the binding of substance P to NK-1 receptors and is ...
K Sharun   +7 more
doaj   +1 more source

Tratamiento de la emesis inducida por citotóxicos [PDF]

open access: yesPsicooncologia, 2004
Nausea and vomiting are important side effects of most chemotherapy anticancer drugs, since nearly two thirds of the patients under chemotherapy have this toxicity in absence of antiemetic treatment.
Miguel Martín, Sara López
doaj   +2 more sources

Use of Coca-Cola drinks in gastric pathology in pediatric patients [PDF]

open access: yesRomanian Journal of Pediatrics, 2020
Facing us the relatively frequent tendency of many people – medical professionals or not – to administer Coca-Colatype carbonated beverages in the case of nausea-type gastric symptoms or vomiting in pediatric or adult patients, we have tried to ...
Cristina Munteanu
doaj   +1 more source

Utilizarea băuturilor de tip Coca-Cola în patologia gastrică la pacienţii pediatrici [PDF]

open access: yesRomanian Journal of Pediatrics, 2020
În faţa tendinţei relativ frecvente a multor persoane – cadre medicale sau nu – de a administra băuturi carbogazoase de tipul Coca-Cola în cazul unor simptome gastrice de tip greaţă sau vărsături la pacienţii pediatrici sau adulţi, am încercat să ...
Cristina Munteanu
doaj   +1 more source

Antiemetic Administration and Its Association with Race: A Retrospective Cohort Study

open access: yesAnesthesiology, 2023
Background: Anesthesiologists’ contribution to perioperative healthcare disparities remains unclear because patient and surgeon preferences can influence care choices.
R. White   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy